Select Medical Hldgs Analyst Ratings
Select Medical Hldgs Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 6.84% | Credit Suisse | $29 → $32 | Maintains | Neutral |
| 07/20/2023 | 26.88% | RBC Capital | → $38 | Reiterates | Outperform → Outperform |
| 05/08/2023 | 26.88% | RBC Capital | $32 → $38 | Maintains | Outperform |
| 05/08/2023 | -3.17% | Credit Suisse | → $29 | Reiterates | → Neutral |
| 02/27/2023 | 30.22% | Benchmark | → $39 | Reiterates | → Buy |
| 02/27/2023 | -3.17% | Credit Suisse | $24 → $29 | Maintains | Neutral |
| 11/07/2022 | 6.84% | RBC Capital | $36 → $32 | Maintains | Outperform |
| 05/17/2022 | -9.85% | Credit Suisse | $28 → $27 | Maintains | Neutral |
| 05/10/2022 | 20.2% | RBC Capital | $42 → $36 | Maintains | Outperform |
| 03/16/2022 | -6.51% | Credit Suisse | $37 → $28 | Maintains | Neutral |
| 03/07/2022 | 40.23% | RBC Capital | $47 → $42 | Maintains | Outperform |
| 01/18/2022 | 16.86% | B of A Securities | $40 → $35 | Maintains | Buy |
| 01/18/2022 | 56.93% | RBC Capital | $50 → $47 | Maintains | Outperform |
| 08/10/2021 | 30.22% | Credit Suisse | $37 → $39 | Maintains | Neutral |
| 05/10/2021 | 53.59% | Deutsche Bank | $42 → $46 | Maintains | Buy |
| 03/01/2021 | 13.52% | Credit Suisse | $32 → $34 | Maintains | Neutral |
| 01/05/2021 | -9.85% | Credit Suisse | $22 → $27 | Maintains | Neutral |
| 11/02/2020 | -26.54% | Credit Suisse | $19 → $22 | Maintains | Neutral |
| 08/04/2020 | -13.19% | Deutsche Bank | $24 → $26 | Maintains | Buy |
| 08/03/2020 | -36.56% | Credit Suisse | $18 → $19 | Maintains | Neutral |
| 06/16/2020 | -49.92% | B of A Securities | $18 → $15 | Downgrades | Neutral → Underperform |
| 05/04/2020 | -39.9% | Credit Suisse | $23 → $18 | Maintains | Neutral |
| 04/24/2020 | -19.87% | Deutsche Bank | $33 → $24 | Maintains | Buy |
| 04/03/2020 | -23.21% | Credit Suisse | $29 → $23 | Maintains | Neutral |
| 03/24/2020 | -16.53% | Benchmark | $33 → $25 | Reiterates | → Buy |
| 02/24/2020 | 10.18% | Deutsche Bank | $22 → $33 | Maintains | Buy |
| 11/04/2019 | -23.21% | Benchmark | $21 → $23 | Maintains | Buy |
| 09/17/2019 | -26.54% | Deutsche Bank | → $22 | Initiates Coverage On | → Buy |
| 05/17/2019 | -39.9% | JMP Securities | → $18 | Upgrades | Market Perform → Market Outperform |
| 01/07/2019 | -46.58% | Credit Suisse | $21 → $16 | Maintains | Neutral |
| 12/14/2018 | -33.22% | Barclays | → $20 | Initiates Coverage On | → Equal-Weight |
| 11/05/2018 | -29.88% | Credit Suisse | $18 → $21 | Maintains | Neutral |
| 10/16/2018 | -39.9% | Credit Suisse | → $18 | Initiates Coverage On | → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/07/2023 | 6.84% | 瑞士信貸 | $29→$32 | 維護 | 中性 |
| 07/20/2023 | 26.88% | 加拿大皇家銀行資本 | →$38 | 重申 | 跑贏→跑贏大盤 |
| 05/08/2023 | 26.88% | 加拿大皇家銀行資本 | $32→$38 | 維護 | 跑贏大盤 |
| 05/08/2023 | -3.17% | 瑞士信貸 | →$29 | 重申 | →中性 |
| 02/27/2023 | 30.22% | 基準 | →$39 | 重申 | →購買 |
| 02/27/2023 | -3.17% | 瑞士信貸 | $24→$29 | 維護 | 中性 |
| 11/07/2022 | 6.84% | 加拿大皇家銀行資本 | $36→$32 | 維護 | 跑贏大盤 |
| 2022/05/17 | -9.85% | 瑞士信貸 | $28→$27 | 維護 | 中性 |
| 2022年05月10日 | 20.2% | 加拿大皇家銀行資本 | $42→$36 | 維護 | 跑贏大盤 |
| 03/16/2022 | -6.51% | 瑞士信貸 | $37→$28 | 維護 | 中性 |
| 03/07/2022 | 40.23% | 加拿大皇家銀行資本 | $47→$42 | 維護 | 跑贏大盤 |
| 01/18/2022 | 16.86% | B of A證券 | $40→$35 | 維護 | 買 |
| 01/18/2022 | 56.93% | 加拿大皇家銀行資本 | $50→$47 | 維護 | 跑贏大盤 |
| 2021/08/10 | 30.22% | 瑞士信貸 | $37→$39 | 維護 | 中性 |
| 2021/05/10 | 53.59% | 德意志銀行 | $42→$46 | 維護 | 買 |
| 03/01/2021 | 13.52% | 瑞士信貸 | $32→$34 | 維護 | 中性 |
| 01/05/2021 | -9.85% | 瑞士信貸 | $22→$27 | 維護 | 中性 |
| 11/02/2020 | -26.54% | 瑞士信貸 | $19→$22 | 維護 | 中性 |
| 08/04/2020 | -13.19% | 德意志銀行 | $24→$26 | 維護 | 買 |
| 08/03/2020 | -36.56% | 瑞士信貸 | $18→$19 | 維護 | 中性 |
| 06/16/2020 | -49.92% | B of A證券 | $18→$15 | 評級下調 | 中性→表現不佳 |
| 05/04/2020 | -39.9% | 瑞士信貸 | $23→$18 | 維護 | 中性 |
| 04/24/2020 | -19.87% | 德意志銀行 | $33→$24 | 維護 | 買 |
| 04/03/2020 | -23.21% | 瑞士信貸 | $29→$23 | 維護 | 中性 |
| 03/24/2020 | -16.53% | 基準 | $33→$25 | 重申 | →購買 |
| 02/24/2020 | 10.18% | 德意志銀行 | $22→$33 | 維護 | 買 |
| 2019/11/04 | -23.21% | 基準 | $21→$23 | 維護 | 買 |
| 2019/09/17 | -26.54% | 德意志銀行 | →$22 | 開始承保 | →購買 |
| 2019年05月17日 | -39.9% | JMP證券 | →$18 | 升級 | 市場表現優於→市場表現 |
| 2019年07月01日 | -46.58% | 瑞士信貸 | $21→$16 | 維護 | 中性 |
| 2018年12月14日 | -33.22% | 巴克萊 | →$20 | 開始承保 | →等重 |
| 2018年11月05日 | -29.88% | 瑞士信貸 | $18→$21 | 維護 | 中性 |
| 2018年10月16日 | -39.9% | 瑞士信貸 | →$18 | 開始承保 | →中性 |
What is the target price for Select Medical Hldgs (SEM)?
精選醫療Hldgs(SEM)的目標價格是多少？
The latest price target for Select Medical Hldgs (NYSE: SEM) was reported by Credit Suisse on August 7, 2023. The analyst firm set a price target for $32.00 expecting SEM to rise to within 12 months (a possible 6.84% upside). 7 analyst firms have reported ratings in the last year.
瑞士信貸於2023年8月7日報告了Select Medical Hldgs(紐約證券交易所代碼：SEM)的最新目標價。這家分析公司將目標價定為32.00美元，預計SEM將在12個月內上漲至6.84%(可能上漲6.84%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Select Medical Hldgs (SEM)?
精選醫療Hldgs(SEM)的最新分析師評級是多少？
The latest analyst rating for Select Medical Hldgs (NYSE: SEM) was provided by Credit Suisse, and Select Medical Hldgs maintained their neutral rating.
瑞士信貸提供了對Select Medical Hldgs(紐約證券交易所代碼：SEM)的最新分析師評級，Select Medical Hldgs維持其中性評級。
When is the next analyst rating going to be posted or updated for Select Medical Hldgs (SEM)?
精選醫療Hldgs(SEM)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Select Medical Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Select Medical Hldgs was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Select Medical Hldgs的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Select Medical Hldgs的上一次評級是在2023年8月7日提交的，因此您應該預計下一次評級將在2024年8月7日左右提供。
Is the Analyst Rating Select Medical Hldgs (SEM) correct?
分析師評級Select Medical Hldgs(SEM)正確嗎？
While ratings are subjective and will change, the latest Select Medical Hldgs (SEM) rating was a maintained with a price target of $29.00 to $32.00. The current price Select Medical Hldgs (SEM) is trading at is $29.95, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Select Medical Hldgs(SEM)評級保持不變，目標價在29.00美元至32.00美元之間。Select Medical Hldgs(SEM)目前的交易價格為29.95美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。